ATF2 antibody

Ref. 3D-20R-1898

Produktinformation

• Name: ATF2 antibody
• Marke: Biosynth
• Beschreibung: The ATF2 antibody is a highly specialized antibody that targets the vascular endothelial growth factor (VEGF), a key growth factor involved in angiogenesis. This antibody specifically binds to the epidermal growth factor receptor (EGFR) and inhibits its signaling pathway, thereby suppressing the growth and proliferation of cancer cells. Additionally, the ATF2 antibody has been shown to induce apoptosis, or programmed cell death, in cancer cells by activating the fas-mediated apoptosis pathway. This monoclonal antibody is produced using state-of-the-art techniques and is highly specific for its target antigen. It can be used for various research applications, including immunohistochemistry, western blotting, and flow cytometry. The ATF2 antibody is a valuable tool for researchers studying cancer biology and developing novel therapeutic strategies against cancer.

Chemische Eigenschaften

• Reinheit: Min. 95%